Because the public release of the results of the game changing thyroiditis study has not moved the share price like they thought it would. And unbelievable, all the miracle stories posted on this board, and all the venom spewing has not affected share price other.
Hmmmm, a real head scratcher.
The head scratcher is why you (the supposed physician/scientist) hasn't gotten back to me on this:
"This study shows nutritional supplementation with anatabine significantly reduces circulating TgAb levels in Hashimoto’s thyroiditis patients. These results confirm an immunologic effect of anatabine in humans as previously shown in a preclinical model of Hashimoto’s thyroiditis."
Keep in mind, once again, the preclinical demonstrated anatabine ameliorated Thyroiditis.